$599
Dexcom Verily G1 Approved, But Will It Launch?
Dexcom’s Verily Gen 1 CGM has received 510(k) clearance ahead of initial projections. Dexcom has not yet issued a press release announcing the approval, but will likely discuss it during the upcoming Q3 ’18 earnings call on November 6. Below, FENIX provides thoughts on the Verily G1 CGM including whether or not Dexcom will even launch the product. Pictured below is a slide from Irl Hirsch’s 2017 talk at AACE comparing Verily G1 (top) and Verily G2 (bottom). The continued CGM innovation back-and-forth between Dexcom and Abbott is very impressive and exciting for patients. Recall, Abbott’s 14-day Libre product and……